×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Healt... [2]
Institute of Chi... [1]
Faculty of Busin... [1]
ASIA-PACIFIC ACA... [1]
THE STATE KEY LA... [1]
Authors
WANG YITAO [1]
DAI YUNLU [1]
LAW CHUN HUNG RO... [1]
Document Type
Journal article [4]
Date Issued
2024 [1]
2023 [1]
2022 [2]
Language
英語English [4]
Source Publication
Advanced Materia... [1]
Cell [1]
Journal of Pharm... [1]
Sustainability [1]
Indexed By
SCIE [4]
SSCI [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-4 of 4
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
High-Lactate-Metabolizing Photosynthetic Bacteria Reprogram Tumor Immune Microenvironment
Journal article
Ma, Yichuan, Hu, Yujing, Liu, Huifang, Li, Xiaoya, Li, Yuanhang, Zhao, Yu, Zhang, Qi, Zhang, Ziyang, Leng, Qingqing, Luo, Li, Li, Lanya, Dai, Yunlu, Chen, Guojun, Zhang, Jinchao, Li, Zhenhua. High-Lactate-Metabolizing Photosynthetic Bacteria Reprogram Tumor Immune Microenvironment[J]. Advanced Materials, 2024, 36(36), 2405930.
Authors:
Ma, Yichuan
;
Hu, Yujing
;
Liu, Huifang
;
Li, Xiaoya
;
Li, Yuanhang
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
27.4
/
30.2
|
Submit date:2024/08/05
Bacteria
Biomaterials
Cancer
Immunotherapy
Lactate Consumption
Tumor Microenvironment
MS/MS fingerprint comparison between adjacent generations enables substructure identification: Flavonoid glycosides as cases
Journal article
Li,Ting, Zhang,Ke, Niu,Xiaoya, Chen,Wei, Yang,Xiangfen, Gong,Xingcheng, Tu,Pengfei, Wang,Yitao, Liu,Wenjing, Song,Yuelin. MS/MS fingerprint comparison between adjacent generations enables substructure identification: Flavonoid glycosides as cases[J]. Journal of Pharmaceutical and Biomedical Analysis, 2023, 234, 115559.
Authors:
Li,Ting
;
Zhang,Ke
;
Niu,Xiaoya
;
Chen,Wei
;
Yang,Xiangfen
; et al.
Favorite
|
TC[WOS]:
6
TC[Scopus]:
5
IF:
3.1
/
3.1
|
Submit date:2023/08/03
Flavonoid Glycosides
Linear Ion Trap
Ms/ms Spectrum Matching
Ms3 Spectrum
Substructure Identification
A Proposed DISE Approach for Tourist Destination Crisis Management
Journal article
Sun, Sunny, Zhong, Lina, Law, Rob, Zhang, Xiaoya, Yang, Liyu, Li, Meiling. A Proposed DISE Approach for Tourist Destination Crisis Management[J]. Sustainability, 2022, 14(17), 11009.
Authors:
Sun, Sunny
;
Zhong, Lina
;
Law, Rob
;
Zhang, Xiaoya
;
Yang, Liyu
; et al.
Favorite
|
TC[WOS]:
1
TC[Scopus]:
4
IF:
3.3
/
3.6
|
Submit date:2022/10/06
Big Data
Covid-19
Crisis Management
Dise Model
Impact
Tourism
Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2
Journal article
Xu, Kun, Gao, Ping, Liu, Sheng, Lu, Shuaiyao, Lei, Wenwen, Zheng, Tianyi, Liu, Xueyuan, Xie, Yufeng, Zhao, Zhennan, Guo, Shuxin, Tang, Cong, Yang, Yun, Yu, Wenhai, Wang, Junbin, Zhou, Yanan, Huang, Qing, Liu, Chuanyu, An, Yaling, Zhang, Rong, Han, Yuxuan, Duan, Minrun, Wang, Shaofeng, Yang, Chenxi, Wu, Changwei, Liu, Xiaoya, She, Guangbiao, Liu, Yan, Zhao, Xin, Xu, Ke, Qi, Jianxun, Wu, Guizhen, Peng, Xiaozhong, Dai, Lianpan, Wang, Peiyi, Gao, George F.. Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2[J]. Cell, 2022, 185(13), 2265-2278.e14.
Authors:
Xu, Kun
;
Gao, Ping
;
Liu, Sheng
;
Lu, Shuaiyao
;
Lei, Wenwen
; et al.
Favorite
|
TC[WOS]:
84
TC[Scopus]:
87
IF:
45.5
/
49.0
|
Submit date:2022/08/02
Covid19 Vaccine
Delta Variant
Immunogen Structure
Omicron Variant
Rbd
Receptor-binding Domain
Sars-cov-2
Vaccine Protection
Variant Of Concern
Voc